Press

PRESS ARTICLES:

‘Drugs target epileptic absence seizures’
Chemical & Engineering News, Feb 20, 2012
Read this Press Article

‘Drug developed to prevent absence seizures’
Epilepsy Research UK, Feb 20, 2012.

‘Research Breakthroughs – Research could prove groundbreaking for treating epilepsy in children’
Total E-Clips No. 2494, Feb 17, 2012.

‘New drug may prevent absence seizures in children’
Calgary Herald, Feb 16, 2012.

‘New drug may prevent absence seizures in children’
Vancouver Sun, Feb 16, 2012.

‘Zalicus publishes data on novel ion channel Compounds’
Reuters, Feb 15, 2012.
Read this Press Article

‘The full text of Zalicus’ press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by …’
Yahoo Finance, Feb 15, 2012.

‘Research could prove groundbreaking for treating epilepsy in children’
Postmedia News, Feb 15, 2012.

‘New drug show promise for preventing absence seizures in children’
MedicalXpress.com, Feb 15, 2012.
Read this Press Article

‘British Columbia’s Universities and our Health Care System: Partnering for Success’
The University Presidents’ Council of British Columbia, Nov 2007, p. 9.

‘Interest in B.C. biotech is on the rebound after lean years’
Vancouver Sun, Oct 27, 2007.

‘Searching for a Better Morphine’
The Journal of Life Sciences Oct 2007, p. 65-70.

‘Canadian researchers are making a name for themselves in pain research – and generating headlines on the business as well as the health pages’
CIHR Annual Report 2006-2007, Oct 2007, p. 35.
Read this Press Article

Neuromed Pharmaceuticals
Annual Report 2007, Brain Research Centre, Sep 2007, p. 9.

Sunday Morning News, Global BC TV, Jun 24, 2007.

‘Honorary SFU Degrees’
Simon Fraser University, Media and Public Relations, Apr 05, 2007, volume 38, no. 7.
Read this Press Article

‘Pumping Ions – Neuromed’s path from research discovery to commercial success’
InnovationCanada.ca, Issue 26, Jan-Feb 2007.

‘Canadian Institutes of Health Research: Publicly-funded research and innovation: Canada’s key to 21st Century’
InnovationCanada.ca, Issue 26, Jan-Feb 2007.

‘From Out of the Shell’
Frontier, Dec 2006, p. 3-5

‘Commercializing Research Discoveries: A new approach to fighting disease’
CIHR Annual Report 05-06, Nov 2006, p. 43.

‘UBC’s a huge innovation machine’
The Province, Sep 22, 2006.
Read this Press Article

‘Merck backs UBC pain research’
Vancouver Sun, Aug 26, 2006, p. A5.

‘A Prison of Pain’
Vancouver Sun, Aug 26, 2006, p. A1.
Read this Press Article

‘Canada must not skimp on health research funds’
Toronto Star, Aug 17, 2006.

‘July Web Profile – CIHR Stimulates the Introduction of Novel Life Sciences Innovations’
Canadian Institutes of Health Research, Jul 2006

‘Funding Excellent Research’
CIHR Annual Report 04-05, Jun 2006, p.10.

‘Quest for Super Painkiller that Won’t Addict’
The Tyee, Jun 27, 2006
Read this Press Article

‘UBC Biotech Spin-off Strikes Record Licensing Deal’
Year in Review 2005-06, UBC Reports, 2006, p. 4.

‘A recipe for success at Neuromed Pharmaceuticals: One part opportunity, one part expertise, and a whole lot of hard work’
Brain Research Centre, June 2006 e-Newsletter Special Feature, Jun 2006.

‘Neuromed Pharmaceuticals Named Life Sciences Company of the Year’
Neuromed Press Release, May 4, 2006

‘UBC spinoff wins biotech award’
Vancouver Sun, Apr 25, 2006, p. D3.

‘Neuromed Named to “Fierce 15″ List of Top Emerging Biotech Companies in 2006′
Neuromed Press Release, Apr 12, 2006

Neuromed is named amoung the winners of the 2006 Fierce 15
Fierce Biotech, Apr 12, 2006
Read this Press Article

‘Grad sparks biotechnology deal’
Simon Fraser University, Media and Public Relations, Apr 5, 2006

‘CIHR-Funded Research: Neuromed Strikes Major R&D Deal with Merck’
CIHR Newsletter, Spring 2006, p. 1.
Read this Press Article

‘Neuromed deal just the beginning – Company’s $500 million licensing contract the richest in Canada’
Vancouver Sun, Mar 24, 2006
Read this Press Article

‘UBC lab’s painkiller brings joy of $475-million deal with Merck’
Vancouver Sun, Mar 21, 2006
Read this Press Article

‘Neuromed Strikes Major Merck Deal’
Globe and Mail, Mar 21, 2006, p. B1.

‘Neuromed lands up to $500M in funding – Merck backs new treatment for chronic pain’
National Post, Mar 21, 2006, p. FP1.
Read this Press Article

‘Neuromed Pharmaceuticals and Merck & Co., Inc. Announce Agreement for Novel N-type Calcium Channel Compounds’
Neuromed Press Release, Mar 20, 2006

‘Sophion Bioscience Install QPatch at University of British Columbia Academic Laboratory’
Sophion Bioscience Press Release, Mar 13, 2006

‘Neuromed Raises US $25 Million Completing Fourth-Round Private Equity Financing’
Neuromed Press Release, Mar 8, 2006

‘Funding Excellent Research’
CIHR Annual Report 2004-2005, 2005, p. 10.

‘Dr. Terrance P. Snutch Receives 2005 PolyPops Foundation Award for Best Conference Presentation’
Society for Biomolecular Sciences, Dec 14, 2005

‘Neuromed Technologies Inc. – From the Research Lab to the Market Place’,
The Innovation Journey of Six Canadian Firms: The Practice of Innovation II. Publication Booklet by Industry Canada, 2004, pp. 36-47.

‘BC Innovation Council recognizes top innovators’,
Business in Vancouver, Nov 2 – 8, 2004.

‘UBC biotech professor wins Innovation Council award’,
The Vancouver Sun, Sep 14, 2004, p. D7.

‘A few biotech success stories will excite VC’s',
Singapore Business Times, Jul 26, 2004.

Top 50 Venture Capital Deals’,
National Post (Business), Jun 2004, p. 180.

‘Biggest stock and debt deals of 2003′,
Business in Vancouver, Mar 30 – Apr 5, 2004, p. B17.

‘Awards recognize local excellence’,
Biotechnology in B.C., 2004, pp. 18-19.

‘NeuroMed starts trial on pain drug candidate’,
Canadian Biotech News, Mar 10, 2004, p. 4.

‘Recent financings bode well for development of biotech’,
Business in Vancouver, Jan 27-Feb 2, 2004, p. 19.

‘NeuroMed Technologies raises US$32 million’,
Silicon Valley North, Nov 4, 2003.

‘NeuroMed lands top round in 2003′,
Business in Vancouver, Nov 11-17, 2003, p. 9.

‘NeuroMed closes $32M financing’,
Canadian Biotech News, Nov 10, 2003, p. 1.

‘MPM Capital leads round for Neuromed’,
The Daily Deal, Nov 5, 2003, p. 5.

‘Neuromed Gets $32M In Third Round to Push Pain Product’,
BioWorld Today, Nov 5, 2003, vol.14 no. 215, p. 1.

‘$32 million for B.C. biotech firm: Neuromed deal is the largest such financing this year’,
The Vancouver Sun, Nov 5, 2003, p. D5.

‘Neuromed completes US$32M financing deal’,
Financial Post, Nov 5, 2003.

‘NeuroMed’,
NeuroInvestment, Apr 2003.

‘NeuroMed Technologies’,
NeuroInvestment, Feb 2003.

‘NeuroMed’,
NeuroInvestment, Jan 2003.

‘Biggest biotech companies in B.C.’,
Business in Vancouver (The List), Jan 28 – Feb 3, 2003.

‘Battle of the Brains’,
Biotechnology Focus, Jun 2002, p. 20.

‘Biotech community expands its reach, opportunities’,
The Vancouver Sun (Believe BC: BC Biotech Special), May 28, 2002.

‘From the Bench – NeuroMed Technologies Inc.: Building value from the bottom up’,
Biotechnology in B.C., May 2002, pp. 34-35.

‘B.C. Biotech Sector is Soaring’,
Globe and Mail (Report on Business Magazine), Apr 2002.

‘N-type Calcium Channels’,
NeuroInvestment, Apr 2002.

‘Ion Channel Modulation’,
NeuroInvestment, Mar 2002.

Emerging Company Profile: ‘NeuroMed: Watching the right channel’,
BioCentury, the Bernstein Report on BioBusiness, Feb 4, 2002.

‘City firms among science winners’,
The Vancouver Sun, Oct 31, 2001, p. D12.

‘A Type ‘N’ Personality: The tale of the scientist and his calcium channels’,
Biotechnology Focus, Jul/Aug 2001, pp 24-25.

‘Neuromed to use $17 million for pain compound trials’,
The Vancouver Sun, Jan 31, 2001.

‘Scientists garner national awards’,
UBC Reports, Dec 14, 2000, p. 1.
Read this Press Article

‘Entrepreneurs face tough choices from startup to public company’,
Biotechnology in B.C. (Growth Strategy), 2000, p. 36.

‘Neuromed Funding Spurs Development of Pain and Stroke Drugs’,
PATSCAN News, Winter 1999, p. 1.

‘Biggest Science Council-administered Technology B.C. grants’,
Business in Vancouver (The List), Oct 19-25, 1999, p. S12.

‘Grant, private funds help stroke drug development’,
Silicon Valley North, Oct 1999.

‘The channels of your mind’,
NeuroMontreal, vol. 3 no. 2 Fall 1999, pp. 8-9.

‘Blocking and Cloning Calcium Channels’,
SYNERGY (Life Sciences), Oct 1998, Issue 4.1, p. 5.

‘Targeting calcium channels’,
CMAJ (Research Update), Aug 11, 1998, 159 (3), p. 215.

‘SFU alumnus Terry Snutch continues to be a rising star in the field of molecular genetics and Canadian science in general.’
Simon Fraser News (Spotlight), Jan 8, 1998 Vol. 11, No.1.

‘UBC researcher wins top Canadian research prize’,
UBC Media Releases, Dec 15, 1997.

‘Life scientist wins prestigious Steacie’,
UBC Reports, Dec 11, 1997 Vol. 43 No. 21, p. 1.
Read this Press Article

‘Channel changer: Prof. Snutch turns the channel on calcium’,
UBC Reports (Profile), Feb 20, 1997.
Read this Press Article

‘UBC scientist’s groundbreaking brain study earns award’,
The West Ender (Body and Soul), Jul 18, 1996, p. 8.

‘Terry Snutch has won the 1996 International Albrecht Fleckenstein Award for his groundbreaking work in neurobiology’,
UBC Reports (People), Jul 11, 1996.

‘Research rewarded: UBC prof goes after calcium’,
The Province, May 12, 1996, p. A25.

‘UBC biochemist wins $45,000 award’,
The Vancouver Sun, May 11, 1996, p. A15.

‘UBC biochemist wins’,
The Province, May 7, 1996.

‘Canadian wins $45,000 medical research prize’,
The German Embassy Ottawa, Vol. 3, No. 2, Summer 1996.

‘Canadian Brain Research’,
MacLean’s, Jan 22, 1996.

‘Scientists Honoured’,
SYNERGY, Oct 1995, Issue 1.1, p. 3.

‘Agency honours health scientists’,
UBC Reports, Aug 17, 1995.

‘Emerging Elite: The New Professionals’,
The Vancouver Sun, Feb 27, 1995.

‘Terry Snutch, an Associate Professor and Howard Hughes International Scholar in UBC’s Biotechnology Laboratory, has been awarded the 1994 Outstanding Alumni Award for Academic Achievement from Simon Fraser University (SFU)’,
UBC Reports (People), Dec 1, 1994.

‘Research effort takes aim at stroke damage’
UBC Reports, Feb 24, 1994.

‘Researchers share $1 million in grants’,
UBC Reports, Aug 15, 1991.

‘The Impact of Health Research: Molecular Genetic Research Attracts Major Pharmaceutical Investment’,
BC Health Research Foundation, 1993, p. 9.

‘Neurobiologist Terry Snutch has been selected as an Alfred P. Sloan Research Fellow’,
UBC Reports, Apr 4, 1991, p. 7.